Literature DB >> 1532282

Restenosis after excimer laser angioplasty of coronary stenoses and chronic total occlusions.

A B Buchwald1, G S Werner, C Unterberg, E Voth, H Kreuzer, V Wiegand.   

Abstract

In an open clinical study, a xenon-chloride excimer laser was used for angioplasty of coronary stenoses (n = 48) and chronic total occlusions (n = 56) in 104 patients. Multifiber catheters (4.0F to 5.5F) transmitted 37 to 120 mjoules/mm2 of fiber surface. Excimer laser angioplasty was successful in 43 patients with a stenosis (89%), followed by percutaneous transluminal coronary angioplasty in 21 patients (49%) to reduce the stenosis to less than 50% luminal narrowing. In 39 patients (70%) with a chronic occlusion (age 1 to 14 months), recanalization by means of excimer laser angioplasty was successful, with subsequent percutaneous transluminal coronary angioplasty performed in 23 patients. Major complications included one perforation, one acute occlusion, and two severe dissections. Six-month angiographic follow-up examinations after successful angioplasty were completed in 40 patients (98%) with stenoses and 34 (94%) with occlusions. Restenosis (greater than 20% decrease in luminal diameter) occurred in 13 patients (33%) with stenoses and in 16 patients (47%) after angioplasty of a chronic occlusion. These long-term results indicate that restenosis after excimer laser angioplasty of coronary stenoses and chronic total occlusions is similar to reported results of conventional balloon angioplasty.

Entities:  

Mesh:

Year:  1992        PMID: 1532282     DOI: 10.1016/0002-8703(92)90691-n

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  1 in total

1.  Balloon Deflection Technique to Facilitate Stent Delivery in Impassable Situations During Percutaneous Coronary Intervention.

Authors:  Prakash Kumar; Santosh Kumar Sinha; Najeeb Ullah Sofi; Mahmodullah Razi; Awdesh Kumar Sharma; Umeshwar Pandey; Praveen Shukla; Ramesh Thakur; Chandra Mohan Varma; Vinay Krishna
Journal:  Cardiol Res       Date:  2021-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.